Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multidrug vs Single Drug Injection for Pain in Total Hip Arthroplasty
NCT03119038Phase 4Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Apr 2016
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, ketorolac, clonidine in postoperative pain, sponsored by Rush University Medical Center. Planned start Apr 2016; status: withdrawn.
02
Drugs
ropivacaineketorolacclonidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03119038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119038.